Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival
about
Establishment of IL-7 Expression Reporter Human Cell Lines, and Their Feasibility for High-Throughput Screening of IL-7-Upregulating ChemicalsEmerging therapeutic targets of sepsis-associated acute kidney injury.IL-18 synergizes with IL-7 to drive slow proliferation of naive CD8 T cells by costimulating self-peptide-mediated TCR signals.Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients.Immunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro.Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantationEfforts of the human immune system to maintain the peripheral CD8+ T cell compartment after childhood thymectomyA rapidly progressing lymphocyte exhaustion after severe sepsis.Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approachThe changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?The new normal: immunomodulatory agents against sepsis immune suppression.Chemoimmunotherapy: reengineering tumor immunity.ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients.Role of cellular events in the pathophysiology of sepsis.Dying to protect: cell death and the control of T-cell homeostasis.[Interleukin-7, a new immunoadjuvant for the treatment of septic shock].T helper type 2-polarized invariant natural killer T cells reduce disease severity in acute intra-abdominal sepsis.The perioperative dynamics of IL-7 following robot-assisted and open colorectal surgery.
P2860
Q28553886-CA0F2962-0FB1-4012-A404-548394BA112EQ30300333-3E793781-9DA2-43DF-9066-0991A535F5DBQ34289372-5EED4EAF-52A8-411B-941E-A8813C8A9FF3Q36057482-055FBA65-049B-49DD-8AAC-E401FEC430E6Q36073299-92395158-D634-41F0-B071-66D14D5C2A20Q36462428-40C53D26-53CF-479B-8CA6-48F96D069F55Q36530581-A818A814-17B9-4329-B0E8-65062CB43AD1Q36633849-E7CFC94A-4F62-4F09-A336-E955633C5010Q37233354-8E6DEE30-00C2-4701-8FC6-535D53DEAC11Q37563023-284220AE-38E9-47C9-A30D-6D2756133D92Q37686624-22BB342C-03B2-414B-A487-721A35CA44EBQ38079749-1A54BB97-D015-4434-B818-10EF9FA35E88Q38413705-F7561B26-5D02-4C3D-8A70-4530FB50B1FEQ38890353-E7A27959-14C5-428D-8784-71E06BE46BA4Q39277476-91B32525-98A3-4B7C-8FA7-9E6590277883Q45241698-5100F92A-488B-4F37-93D2-89CFCF370141Q51071957-1DB3A143-B18E-47DC-B3D1-11A575C5FCEFQ55381850-6C041BC6-4C7E-4CBB-B7E9-A20275340CDD
P2860
Interleukin-7 and immune reconstitution in cancer patients: a new paradigm for dramatically increasing overall survival
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Interleukin-7 and immune recon ...... ly increasing overall survival
@en
Interleukin-7 and immune recon ...... y increasing overall survival.
@nl
type
label
Interleukin-7 and immune recon ...... ly increasing overall survival
@en
Interleukin-7 and immune recon ...... y increasing overall survival.
@nl
prefLabel
Interleukin-7 and immune recon ...... ly increasing overall survival
@en
Interleukin-7 and immune recon ...... y increasing overall survival.
@nl
P2860
P921
P1433
P1476
Interleukin-7 and immune recon ...... ly increasing overall survival
@en
P2093
Michel Morre
Stéphanie Beq
P2860
P2888
P356
10.1007/S11523-012-0210-4
P577
2012-03-01T00:00:00Z
2012-03-02T00:00:00Z